Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab.

Cancer Med · 2013 · PMC3639662 · PMID 23634291

Europe PMC DOI

hedged sentence

0.5300

closest p · 10.6× alpha

0.5300

boldest claim

The sentences

did not reach statistical significanceP = 0.53not close (p > 0.1)

Soluble VEGF-R1 was also decreased in 22 of 38 patients, although it did not reach statistical significance ( P = 0.53).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.